Cite
MLA Citation
Michelle J. Pena et al.. “The effects of atrasentan on urinary metabolites in patients with type 2 diabetes and nephropathy.” Diabetes, obesity & metabolism, vol. 19, no. 5, 2017, pp. 749–753. http://access.bl.uk/ark:/81055/vdc_100045730955.0x00000a